|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
|Ticker||Company||Price||Change||Chg %||Mkt Cap|
You can purchase shares of NervGen Pharma (OTC: NGENF) through any online brokerage.
There are no as such competitors for NervGen Pharma.
The latest price target for NervGen Pharma (OTC: NGENF) was reported by Industrial Alliance on July 13, 2021. The analyst firm set a price target for 6.00 expecting NGENF to rise to within 12 months (a possible 257.29% upside). 1 analyst firms have reported ratings in the last year.
The stock price for NervGen Pharma (OTC: NGENF) is $1.6793 last updated Fri Sep 24 2021 19:31:40 GMT+0000 (Coordinated Universal Time).
There are no upcoming dividends for NervGen Pharma.
NervGen Pharma does not have any upcoming earnings scheduled.
There is no upcoming split for NervGen Pharma.
NervGen Pharma is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on the OTC.